Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Authors:

Abstract
No abstract available
Funding Information
  • Clovis Oncology
  • US Department of Defense Ovarian Cancer Research Program (OC120506)
  • V Foundation Translational Award
  • Stand Up To Cancer—Ovarian Cancer Research Fund Alliance—National Ovarian Cancer Coalition Dream Team Translational Research Grant (SU2C-AACR-DT16-15)
  • Ann Rife Cox Chair in Gynecology
  • Judy Reis (Al Pisani) Ovarian Cancer Research Fund (RLC)
  • UCH/UCL Biomedical Research Centre (RK)
  • Experimental Cancer Medicine Centres at UCL (RK)

This publication has 39 references indexed in Scilit: